Overview

A Safety and Efficacy Study to Evaluate Rosacea

Status:
Not yet recruiting

Trial end date:
2022-08-01

Target enrollment:

Participant gender:

Summary

To evaluate the safety, efficacy, and pharmacokinetic profile of ascending concentrations of the study medication compared with vehicle in subjects with rosacea.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Aiviva BioPharma Inc.
AiViva BioPharma, Inc.